A2 Milk share price collapses 6% as CEO steps down
We examine the details behind Jayne Hrdlicka’s decision to step down from her role as Chief Executive Officer at the a2 Milk Company.
It was hardly a surprising reaction from the market this morning: A2 Milk’s share price fell as much as 6% after the company announced that MD and CEO Jayne Hrdlicka would step down from her role.
By 10:27 AEDT, A2M traded just below the $14 mark – at $13.930 per share.
In response to this news, A2’s Board noted that they would immediately commence a global search for a replacement Chief Executive – with the company's former CEO, Geoffrey Babbidge, set to take reigns as Interim CEO in the meantime.
Mr Babbidge served as A2’s CEO from 2010 to July 2018, overseeing the company as it went through an explosive phase of growth. Specifically, from a2 Milk’s ASX-listing in 2015 to 2018 – the share price ran up more than 1,600% – as the company saw its revenue and earnings rise at an exponential rate.
A2 Milk share price: a new path forward?
Speaking of the broad implications of Hrdlicka’s decision to step down, A2M’s Board attempted to reassure investors, noting that it:
‘Remains confident that the strategic course of the business which was recently communicated at the Annual Meeting will continue to deliver strong rewards to all shareholders in the future.'
Evidently dissatisfied with the potentially turbulence that this C-suite shakeup would create, by 11:12 AEDT A2M’s stock continued to dive, dropping 6.09% to $13.66 per share.
Commenting on the decision herself, Jayne Hrdlicka stressed how delighted she was over the progress that has been made at the company in recent times, as well as her confidence in the company’s current leadership team's ability to execute on the current strategic-growth plan.
'The reality however is that the next 3-5 years will continue to require the CEO being present in our core markets of China and the US and that combined with running a New Zealand company based in Australia required more travel than I had anticipated.'
She further continued by saying that, 'the Board and I agreed that this next phase is going to be too difficult to manage alongside my other commitments whilst also managing the health and wellness priorities of my family and me.'
A broader issue at play
Analysts, and the market more broadly appeared to express dissatisfaction with the aggressive growth plans – spearheaded by Hrdlicka herself – that would of seen A2’s marketing spend upsized while its margins compressed. he stock fell after strongly after its FY19 results revealed the company expected (EBITDA) margins in the realm of 28%.
On the side of all this, an article from the Australian Financial Review today suggested that there may have been tension between Hrdlicka and the board over strategy; namely, over balancing growth and margins, and how to do so appropriately.
Indeed, the stock did rise around 30% – from November to December – after the company recently announced it expected its margins to be higher than previously flagged. A2's marketing spend will remain signifcant in FY20.
Tellingly, in an A2 investor briefing also released this morning, the company's CFO David Hearn stressed that the company will 'target an EBITDA margin of at least 30% in the medium term.'
A goal the Board views as achievable, without much detriment to growth, he added.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Act on share opportunities today
Go long or short on thousands of international stocks with spread bets and CFDs.
- Get full exposure for a comparatively small deposit
- Trade on spreads from just 0.1%
- Get greater order book visibility with direct market access
See opportunity on a stock?
Try a risk-free trade in your demo account, and see whether you’re on to something.
- Log in to your demo
- Take your position
- See whether your hunch pays off
See opportunity on a stock?
Don’t miss your chance – upgrade to a live account to take advantage.
- Trade a huge range of popular stocks
- Analyse and deal seamlessly on fast, intuitive charts
- See and react to breaking news in-platform
See opportunity on a stock?
Don’t miss your chance. Log in to take advantage while conditions prevail.
Live prices on most popular markets
You might be interested in…
Find out what charges your trades could incur with our transparent fee structure.
Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.
Stay on top of upcoming market-moving events with our customisable economic calendar.